Projects

Ing. Miroslav Ferko, PhD.

International

Finished
  • Study of the triggering mechanisms and transmission of cardioprotective signals induced by noninvasive adaptive stimuli
    Program: Inter-academic agreement
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Effect of pathological states on cardiac resistance against myocardial ischemia: study of molecular mechanisms and novel approaches to cardioprotection
    Program: Inter-academic agreement
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Study of clinically applicable novel forms of preconditioning as an alternative method of cardiac protection against acute ischemia in the organism challenged with civilization diseases
    Program: Inter-governmental agreement
    Duration: 1. 1. 2015 – 31. 12. 2015
  • Study of endogenous cardioprotective mechanisms against myocardial ischemia
    Program: Inter-academic agreement
    Duration: 1. 1. 2009 – 31. 12. 2014
  • IVF grant New Frontiers in Basic Cardiovascular Research 2014
    Program: Other
    Duration: 1. 2. 2014 – 30. 7. 2014
  • The effect of lifestyle-related risk factors on the intrinsic defensive mechanisms in the myocardium
    Program: Inter-governmental agreement
    Duration: 1. 1. 2012 – 31. 12. 2013
  • Activation of cellular adaptive processes as a potential target of cardiac protection against ischaemic injury
    Program: Inter-governmental agreement
    Duration: 1. 1. 2008 – 1. 12. 2009

National

Current
  • -
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • On the trace of mitochondrial chloride channel identity.
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Cardiac mitochondrial bioenergetics regulated by reduced oxygen consumption: In-depth proteomic analysis of cardioprotective signaling pathways.
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmias
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Study of the role of innate cardioprotection in the rat myocardium evoked by non-pharmacological adaptive stimuli under normal and pathological conditions.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
Finished
  • -
    Program: Other projects
    Duration: 1. 10. 2023 – 31. 3. 2024
  • -
    Program: Other projects
    Duration: 1. 6. 2023 – 31. 12. 2023
  • Crosslinking of some necrosis-like forms of cell death: signaling and a multi-targeting tool to mitigate heart damage due to ischemia?
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • -
    Program: Other projects
    Duration: 1. 10. 2022 – 31. 3. 2023
  • -
    Program: Other projects
    Duration: 10. 11. 2021 – 31. 3. 2022
  • Mitochondria as a key effector in processes of cardioprotective intervention
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Dynamics of myocardial damage: a role of necroptotic cell death and survival of cardiomyocytes.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Study of endogenous compensatory mechanisms effective against energy deficiency in pathologycally loaded myocardium: Innovative approaches in experimental cardioprotection.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • -
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Bioenergetic aspects of myocardial protection by means of remote ischemic preconditioning. The role of cardiac mitochondria
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Study of the clinically relevant forms of preconditioning as an alternative method of myocardial protection against acute ischemia in the organism challenged with civilization diseases
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Multifunctional activity of calcium/calmodulin dependent protein kinase II (CaMKII) in the heart: a relevance to disturbances in heart rhythm, contractility and cellular death.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • The effect of the lifestyle-related risk factors on the adaptive processes in the ischemic myocardium
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Centre of excellence of SAS for research of regulatory role of nitric oxide in civilization diseases
    Program:
    Duration: 1. 8. 2011 – 30. 6. 2015
  • The role of mitochondria in adaptation of cardiac energetics to various pathological stimuli and noxae: ischemia, diabetes, hypertension
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2014
  • Modulatory effect of lifestyle-related risk factors on the mechanisms of subcellular adaptation to myocardial ischemia
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Influence of hypercholesterolemia on endogenous adaptive mechanisms in early stage of diabetes: interference with hypolipidemic agents.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2011
  • Cell signaling pathways and transcription factor activation in adaptive processes in the myocardium as an alternative approach to antiischemic protection
    Program: VEGA
    Duration: 1. 1. 2008 – 1. 12. 2010
  • Effect of selected types of antihypertensive therapy on the functional properties of mitochondria and on selected calcium-modulated signalling pathways in heart and kidneys of rats with genetically determined hypertension
    Program: VEGA
    Duration: 1. 1. 2007 – 1. 12. 2009
  • Interactions of cell signaling mechanisms in the processes of myocardial ischemic injury and endogenous cardioprotection
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees